{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:42:26Z","timestamp":1772552546591,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pharma.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:53:21Z","timestamp":1771358001000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019\u20132020)"],"prefix":"10.1016","author":[{"given":"Hala","family":"El Hachimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheikh","family":"Yebouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimetou","family":"khiddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Mahmoud","family":"El Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Vall Mohamed","family":"Abdellahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2026.02.006_bib0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/liv.12135","article-title":"Hepatitis B virus in the Maghreb region: from epidemiology to prospective research","volume":"33","author":"Ezzikouri","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.pharma.2026.02.006_bib0155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3345\/kjp.2016.59.12.461","article-title":"Recommended immunization schedule for children and adolescents: immunization guideline released by the Korean Pediatric Society in 2015","volume":"59","author":"Kim","year":"2016","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.pharma.2026.02.006_bib0160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1473-3099(15)00158-9","article-title":"Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy","volume":"15","author":"Thio","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pharma.2026.02.006_bib0165","series-title":"Global hepatitis report 2017","year":"2017"},{"key":"10.1016\/j.pharma.2026.02.006_bib0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.11604\/pamj.2017.26.154.11594","article-title":"Pr\u00e9valence de l\u2019antig\u00e8ne de surface du virus de l\u2019h\u00e9patite B et facteurs associ\u00e9s chez des militaires s\u00e9n\u00e9galais envoy\u00e9s en mission au Darfour","volume":"26","author":"Moustapha","year":"2017","journal-title":"Pan Afr Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.pharma.2026.02.006_bib0175","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.pharma.2026.02.006_bib0180","doi-asserted-by":"crossref","first-page":"328","DOI":"10.11604\/pamj.supp.2017.27.3.11981","article-title":"The status of hepatitis B control in the African region","volume":"27","author":"Breakwell","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.pharma.2026.02.006_bib0185","series-title":"Politique nationale de sant\u00e9 \u00e0 l\u2019horizon 2030","year":"2019"},{"key":"10.1016\/j.pharma.2026.02.006_bib0190","series-title":"Annuaire statistique de la Mauritanie 2019","year":"2019"},{"key":"10.1016\/j.pharma.2026.02.006_bib0195","series-title":"HBsAg Rapicard\u00ae: rapid diagnostic test package insert","year":"2021"},{"key":"10.1016\/j.pharma.2026.02.006_bib0200","first-page":"247","article-title":"Infection par le virus de l\u2019h\u00e9patite B en milieu scolaire \u00e0 Kiffa et S\u00e9libaby (Mauritanie)","volume":"91","author":"Rui","year":"1998","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.pharma.2026.02.006_bib0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.11604\/pamj.2017.28.118.12465","article-title":"Estimation of seroprevalence of HIV, hepatitis B and C virus and syphilis among blood donors in the hospital of A\u00efoun, Mauritania","volume":"28","author":"Boushab","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.pharma.2026.02.006_bib0210","first-page":"83","article-title":"Pr\u00e9valence des marqueurs s\u00e9rologiques des h\u00e9patites B et C chez les donneurs de sang \u00e0 Nouakchott (Mauritanie)","volume":"92","author":"Lo","year":"1999","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.pharma.2026.02.006_bib0215","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.23336","article-title":"Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and patients in Mauritania","volume":"84","author":"Mansour","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.pharma.2026.02.006_bib0220","first-page":"621","article-title":"Marqueurs s\u00e9rologiques utilis\u00e9s dans la surveillance de l\u2019h\u00e9patite B au Togo\u00a0: \u00e9tat des lieux et propositions d\u2019actions","volume":"68","author":"Agbenu","year":"2008","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.pharma.2026.02.006_bib0225","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tracli.2009.09.004","article-title":"HIV, HCV, HBV and syphilis rates among blood donors in Mali: lower rates among volunteer donors","volume":"16","author":"Diarra","year":"2009","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.pharma.2026.02.006_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.respe.2012.12.018","article-title":"S\u00e9ropr\u00e9valence des marqueurs infectieux chez les donneurs de sang \u00e0 Niamey (Niger)","volume":"61","author":"Mayaki","year":"2013","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.pharma.2026.02.006_bib0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/1119-3077.151035","article-title":"Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis","volume":"18","author":"Musa","year":"2015","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.pharma.2026.02.006_bib0240","first-page":"2493","article-title":"Hepatitis B virus biology","volume":"81","author":"Seeger","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.pharma.2026.02.006_bib0245","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13104-018-3218-8","article-title":"Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012\u20132013","volume":"11","author":"Ansumana","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.pharma.2026.02.006_bib0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-3156.2011.02902.x","article-title":"Seroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors in Burkina Faso","volume":"17","author":"Nagalo","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.pharma.2026.02.006_bib0255","doi-asserted-by":"crossref","first-page":"ckz187","DOI":"10.1093\/eurpub\/ckz187.076","article-title":"Prevalence and risk factors of hepatitis B in Tunisia","volume":"29","author":"Lahchaichi","year":"2019","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.pharma.2026.02.006_bib0260","first-page":"e47066","article-title":"Seroprevalence of HIV, hepatitis C virus and hepatitis B virus among blood donors in Sidi Bel Abbes, West Algeria","volume":"15","author":"Belkacemi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.pharma.2026.02.006_bib0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.11604\/pamj.2019.33.163.18688","article-title":"Prevalence of hepatitis B and C in a blood transfusion center in Oujda, Morocco (2013\u20132015)","volume":"33","author":"Boubker","year":"2019","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.pharma.2026.02.006_bib0270","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.patbio.2011.06.001","article-title":"Pr\u00e9valence de l\u2019infection par le virus de l\u2019h\u00e9patite B et \u00e9valuation des facteurs de risque au Maroc","volume":"60","author":"Sbai","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.pharma.2026.02.006_bib0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2052-1839-14-5","article-title":"HIV, HBV, HCV and Treponema pallidum infections among blood donors in Douala, Cameroon","volume":"14","author":"Eboumbou Moukoko","year":"2014","journal-title":"BMC Hematol"},{"key":"10.1016\/j.pharma.2026.02.006_bib0280","first-page":"97","article-title":"S\u00e9ropr\u00e9valence du VIH et des h\u00e9patites B et C chez les donneurs de sang \u00e0 S\u00e9gou (Mali)","volume":"22","author":"Kon\u00e9","year":"2012","journal-title":"Med Sante Trop"},{"key":"10.1016\/j.pharma.2026.02.006_bib0285","first-page":"293","article-title":"Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, Nigeria","volume":"7","author":"Buseri","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.pharma.2026.02.006_bib0290","series-title":"WHO and UNICEF estimates of immunization coverage: Mauritania, 2022 revision","author":"United Nations Children's Fund","year":"2023"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450926000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:30:52Z","timestamp":1772541052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450926000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":29,"alternative-id":["S0003450926000313"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2026.02.006","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B in transition in Mauritania: HBsAg seroprevalence in patients attending the Cheikh Zayed National Hospital, Nouakchott (2019\u20132020)","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}